Genetic polymorphism of 5,10-methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population
- 1 February 2000
- journal article
- pathophysiology and-natural-history
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 11 (1) , 47-51
- https://doi.org/10.1097/00019501-200002000-00009
Abstract
Background Hyperhomocysteinemia, an independent and graded risk factor for coronary artery disease, can result from both environmental and hereditary factors. C677T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene [alanine/valine (A/V) polymorphism], one of the key enzymes involved in catalyzing the remethylation of homocysteine, has recently been reported. Objective To evaluate the incidence of the MTHFR genotypes and their significance in determining the risk for myocardial infarction of Japanese men. Method The subjects consisted of 199 healthy men (mean age, 60 years) and 230 male patients with myocardial infarction (mean age, 59 years). The coronary-artery lesions were evaluated by coronary angiography. The MTHFR genotype was analyzed by polymerase chain reaction and then by digestion with HinfI. Total plasma levels of homocysteine for each MTHFR genotype were compared with those in healthy controls. Results The prevalences of the A and V alleles among the healthy male subjects were 0.652 and 0.348 in the Hardy–Weinberg equilibrium. The total levels of homocysteine in the plasma of the healthy male subjects were 8.6±3.3, 8.9±4.1, and 11.6±5.6 mmol/l, for AA, AV, and VV genotypes, respectively. Individuals with the VV homozygous mutant genotype thus had the highest plasma levels of homocysteine. Logistic analysis revealed that the levels of high-density lipoprotein cholesterol, hypertension, diabetes mellitus, MTHFR VV genotype, and triglycerides were all independent risk factors for myocardial infarction. The VV genotype was more prevalent among patients with myocardial infarction (mean age, 59 years) than it was among the control subjects (17.0 versus 10.6%, P <0.05). However, there were no differences in the numbers of stenotic coronary arteries among the MTHFR genotypes. Conclusion The VV genotype of MTHFR increases plasma levels of homocysteine in healthy controls, and this mutation indicates a genetic predisposition toward a greater than normal risk of myocardial infarction for Japanese men.Keywords
This publication has 22 references indexed in Scilit:
- Homocysteine, Vitamins, and Cardiovascular DiseaseCirculation, 1998
- C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populationsAtherosclerosis, 1998
- Myocardial Infarction in Young Women in Relation to Plasma Total Homocysteine, Folate, and a Common Variant in the Methylenetetrahydrofolate Reductase GeneCirculation, 1997
- Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- Annotation Molecular genetics of methylenetetrahydrofolate reductase deficiencyJournal of Inherited Metabolic Disease, 1996
- Serum folate and risk of fatal coronary heart diseaseJAMA, 1996
- Serial measures of plasma homocyst(e)ine after acute myocardial infarctionThe American Journal of Cardiology, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1987